Johnson & Johnson is conducting a voluntary recall of millions of oral contraceptive packages in 43 countries outside the U.S., but the health care giant says there's a "very low" risk that the flawed tablets could cause ...
not rated yet |
0
Daiichi Sankyo believed it had scored a coup in 2008 when it outbid rivals to buy Indian generics giant Ranbaxy for $4.6 billion but its foray into the high-growth copycat drugs arena has brought the Japanese drugmaker only ...
not rated yet |
0
In the first genome-wide association study to focus on warfarin dose requirement in African-Americans, a multi-institutional team of researchers has identified a common genetic variation that can help physicians estimate ...
not rated yet |
0
A former blockbuster diabetes pill that was subjected to major safety restrictions in 2010 may be less risky than once thought, according to the latest analysis of the much-debated GlaxoSmithKline drug Avandia.
not rated yet |
0
Arena Pharmaceuticals says its weight loss drug Belviq will be available to U.S. patients beginning next week, nearly a year after the drug was officially approved by federal regulators.
5 / 5 (1) |
0
(Medical Xpress) -- A new pharmaceutical program that many Britons might find literally hard to swallow, has been announced. Pharmacy chain Lloydspharmacy has partnered with American technology firm Proteus ...
4.1 / 5 (13) |
3
|
NSAIDs have been the cornerstone in managing pain in people with inflammatory disorders like rheumatoid arthritis, and are some of the most commonly used drugs worldwide. Earlier research has linked their use with an increased ...
not rated yet |
0
(Medical Xpress)—New research from the University of Reading, The Royal Botanic Gardens, Kew and Imperial College London published on 10 September in the Proceedings of the National Academy of Sciences (PNAS) ...
5 / 5 (6) |
0
|
Dapagliflozin (trade name: Forxiga) has been approved in Germany since November 2012 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal ...
not rated yet |
0
An EU medicines watchdog on Thursday endorsed the safety of acne drug Diane-35, also widely used as a contraceptive, despite protests from France, which has suspended its use.
not rated yet |
0
The first enterovirus 71 (EV71) vaccine candidate to reach phase 3 clinical testing provides young Chinese children with significant protection against disease caused by EV71, a growing public-health threat which has caused ...
5 / 5 (1) |
0
(Medical Xpress)—The results of a phase 1/2 clinical trial in Europe of an investigational Lyme disease vaccine co-developed by researchers at Stony Brook University, Brookhaven National Laboratory, and at Baxter International ...
not rated yet |
0
|
Scientists at Harvard may have new hope for anyone who's tried to fight the battle of the bulge. New research, conducted in collaboration with researchers at Massachusetts General Hospital, has found that the gut microbes ...
4.5 / 5 (4) |
0
|
(Medical Xpress) -- The Food and Drug Administration in the United States has approved a request by Proteus Digital Health to allow for the inclusion of tiny digestible microchips into medicines to assist ...
3.8 / 5 (5) |
3
|
People who take the newest class of diabetes drugs to control blood sugar are twice as likely as those on other forms of sugar-control medication to be hospitalized with pancreatitis, Johns Hopkins researchers report.
5 / 5 (2) |
1
|
